IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells

Chronic lymphocytic leukemia (CLL) displays constitutive phosphatidylinositol 3-kinase (PI3K) activation resulting from aberrant regulation of B-cell receptor (BCR) signaling. Previous studies have shown that an oral PI3K p110δ inhibitor idelalisib exhibits promising activity in CLL. Here, we demons...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Dong, Shuai, Guinn, Daphne, Dubovsky, Jason A., Zhong, Yiming, Lehman, Amy, Kutok, Jeffery, Woyach, Jennifer A., Byrd, John C., Johnson, Amy J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2014
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256910/
https://ncbi.nlm.nih.gov/pubmed/25258342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-587279
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller